Osaic Holdings
CYTK icon

Osaic Holdings’s Cytokinetics CYTK Stock Holding History

Osaic Holdings’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27M Sell
50,087
-785
-2% -$56.4K 0.01% 1655
2026
Q1 		$3.35M Sell
50,872
-1,564
-3% -$99.4K ﹤0.01% 1647
2025
Q4 		$3.33M Sell
52,436
-2,297
-4% -$143K ﹤0.01% 1681
2025
Q3 		$2.91M Buy
54,733
+48,820
+826% +$2.01M ﹤0.01% 1871
2025
Q2 		$196K Buy
5,913
+833
+16% +$29K ﹤0.01% 3964
2025
Q1 		$204K Sell
5,080
-669
-12% -$30.7K ﹤0.01% 3609
2024
Q4 		$259K Buy
5,749
+260
+5% +$13.5K ﹤0.01% 3374
2024
Q3 		$290K Buy
5,489
+2,974
+118% +$166K ﹤0.01% 3344
2024
Q2 		$136K Sell
2,515
-268
-10% -$16.2K ﹤0.01% 3888
2024
Q1 		$195K Sell
2,783
-3,776
-58% -$292K ﹤0.01% 3711
2023
Q4 		$548K Sell
6,559
-376
-5% -$13.6K ﹤0.01% 3084
2023
Q3 		$204K Buy
6,935
+1,474
+27% +$49.1K ﹤0.01% 3977
2023
Q2 		$184K Buy
5,461
+274
+5% +$10.1K ﹤0.01% 3953
2023
Q1 		$182K Sell
5,187
-99
-2% -$4.04K ﹤0.01% 3941
2022
Q4 		$242K Sell
5,286
-4,347
-45% -$187K ﹤0.01% 3687
2022
Q3 		$467K Sell
9,633
-15,553
-62% -$749K ﹤0.01% 2962
2022
Q2 		$992K Buy
25,186
+19,256
+325% +$775K ﹤0.01% 2274
2022
Q1 		$154K Buy
5,930
+767
+15% +$27.3K ﹤0.01% 4238
2021
Q4 		$235K Buy
5,163
+979
+23% +$37.8K ﹤0.01% 3798
2021
Q3 		$151K Buy
4,184
+87
+2% +$2.56K ﹤0.01% 4163
2021
Q2 		$83K Buy
4,097
+196
+5% +$4.6K ﹤0.01% 4648
2021
Q1 		$92K Buy
3,901
+1,176
+43% +$25.1K ﹤0.01% 4406
2020
Q4 		$55K Buy
2,725
+1,342
+97% +$24.5K ﹤0.01% 4486
2020
Q3 		$33K Hold
1,383
– – ﹤0.01% 4593
2020
Q2 		$33K Sell
1,383
-106
-7% -$1.99K ﹤0.01% 4464
2020
Q1 		$18K Buy
+1,489
New +$19K ﹤0.01% 4691

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's CYTK Position: Q2 2026 in Review

Osaic Holdings reduced its Cytokinetics (CYTK) stake by 1.5% in Q2 2026, selling an estimated $56.4K and leaving 50,087 shares worth $4.27M. The position accounts for 0.01% of the portfolio, ranked #1655.

Osaic Holdings first reported a position in CYTK in Q1 2020 and has held it in 26 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Osaic Holdings held 50,087 shares of Cytokinetics worth $4.27M as of Q2 2026.
  • Osaic Holdings sold 785 Cytokinetics shares in Q2 2026, an estimated $56.4K.
  • Cytokinetics made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1655 holding.
  • Osaic Holdings first reported a position in Cytokinetics in Q1 2020 and has held it in 26 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.